01—Abstract
Summary
Summary of the 8-K filed July 2, 2025. Cited figures are marked; the original filing is the authoritative source.
On July 2, 2025, Bunge Global SA (NYSE: BG) completed its acquisition of Viterra Limited, a privately held Jersey-incorporated agribusiness, creating a combined global agribusiness platform.
Bunge acquired all Viterra shares from the Sellers (Glencore, CPP Investments, BCI and the Viterra Employee Benefit Trust) by issuing approximately 65.6 million registered shares valued at about $5.3 billiona and paying approximately $2.0 billion in cash. The Sellers, excluding the Viterra EBT, now collectively own roughly 33% of Bunge's registered shares, a significant change in the shareholder base. Bunge withheld $150 million of cash consideration pending agreement on Danube Leakage calculations, and the cash portion was funded from cash on hand and existing debt instruments.
The filing also documents governance and shareholder arrangements tied to the closing, including Shareholder's Agreements with Glencore and CPPIB, a Registration Rights Agreement, and a BCI lock-up agreement. Four Board members nominated by CPPIB and Glencore take their seats upon closing, and David Mattiske, Viterra's former CEO, joined as Co-Chief Operating Officer alongside Julio Garros. Exhibit 99.4 indicates Bunge drew $2.3 billionb of an $8.0 billion acquisition financing package on June 30, 2025 and used proceeds from senior notes and cash to repay a portion of Viterra's debt.
Pro forma figures show Q1 2025 pro forma net income attributable to Bunge of $63 millionc ($0.31 per diluted share) versus a 2024 pro forma figure of $1,168 million ($5.62 per diluted share), reflecting the larger share count, purchase accounting, and financing effects. Investors should weigh the meaningful dilution and ownership concentration against the expected scale, diversification and synergy benefits, which management has not quantified in this filing.
The pro forma statements are preliminary and subject to change as purchase price allocation is finalized within one year, so the goodwill of roughly $2.1 billiond and fair-value adjustments may shift materially. The combined company's leverage has also increased substantially, given that Bunge assumed or repaid large Viterra debt balances and drew new acquisition financing.
02—Key points
Key Highlights
- Closed the Viterra acquisition on July 2, 2025: acquired 100% of Viterra for ~65.6M Bunge shares (~$5.3B) plus ~$2.0B cash.
- Sellers (Glencore, CPPIB, BCI, Viterra EBT) collectively own ~33% of Bunge's registered shares following the transaction, a major shift in ownership concentration.
- $150 million of cash consideration withheld pending agreement on Danube Leakage and Danube Permitted Leakage calculations with Sellers.
- Bunge drew $2.3B of an $8.0B acquisition financing package on June 30, 2025, alongside senior notes proceeds and cash to fund cash consideration and repay Viterra debt.
- Shareholder, registration rights and BCI lock-up agreements executed, with CPPIB and Glencore nominees (Isman, Jensen, Mahoney, Walt) joining the Board through the 2026 AGM.
- Pro forma Q1 2025 EPS of $0.31 (diluted) vs. 2024 pro forma diluted EPS of $5.62, reflecting larger share count and purchase accounting effects; purchase price allocation remains preliminary with goodwill of ~$2.1B.
- David Mattiske, former Viterra CEO, appointed Co-Chief Operating Officer alongside Julio Garros, with a 150% target bonus and $3.0M one-time RSU award.
03—Questions
Frequently Asked Questions
How much did Bunge pay for Viterra and how was it structured?
Bunge issued approximately 65.6 million registered shares to the Sellers, valued at roughly $5.3 billion (based on the June 27, 2025 NYSE closing price for pro forma purposes), and paid approximately $2.0 billion in cash. The Viterra Employee Benefit Trust received cash in lieu of shares. Including debt Bunge repaid at closing (about $4.5 billion per the pro forma), the total economic outlay is substantially larger than the headline consideration.
Who now owns Bunge, and what does this mean for existing shareholders?
The Sellers, excluding the Viterra EBT, now own about 33% of Bunge's registered shares. This materially dilutes existing shareholders' ownership and creates a concentrated block held by Glencore, CPP Investments and BCI/BCIMC, which is subject to shareholder agreements, registration rights and a lock-up for BCI. The pro forma weighted share count rises from about 140.5 million to about 206.2 million for 2024.
What governance changes came with the closing?
Adrian Isman and Anne Jensen (CPPIB nominees) and Christopher Mahoney and Markus Walt (Glencore nominees) joined the Board, each serving until the 2026 annual general meeting. David Mattiske, Viterra's former CEO, became Co-Chief Operating Officer alongside Julio Garros, jointly overseeing commercial activities, global commodity value chains, renewable fuels and industrial operations.
How is the deal being financed and what are the leverage implications?
The cash consideration was funded from cash on hand and existing debt instruments, and Bunge drew $2.3 billion from an $8.0 billion acquisition financing package on June 30, 2025. Proceeds from three tranches of senior notes ($2.0 billion issued in September 2024) were also used. Bunge also assumed or repaid Viterra's borrowings, which were about $8.8 billion at March 31, 2025, so the combined company carries materially higher debt that investors should monitor against cash flow and credit metrics.
Are the financial figures in this filing final?
No. The purchase price allocation, fair value of acquired assets and liabilities, goodwill (~$2.1 billion) and the Danube Leakage calculation are all preliminary and may change materially within the one-year measurement period. The pro forma statements exclude anticipated synergies, cost savings and integration costs, so reported results will differ from these illustrative figures.
04—Continue